But there will be NO additional contribution to trust…
GigCapital, Inc. (GIG) filed their Definitive Proxy this afternoon and while there was always the hope that they would drop in an additional contribution to trust while it was still a Preliminary Statement, that hope is gone now. There will be no additional contribution for shareholders that do not redeem at the upcoming extension vote. Gig’s vote to extend their deadline from June 12th to December 12th, 2019, will take place on June 5th, with a record date of April 26th.
As a reminder, Gig had 15 months to complete a business combination, but extended an additional 3-months to June 12th, back in March. At that time, Gig contributed an additional $0.10 per share to trust for shareholders that did not redeem, per their Charter (they didn’t have a choice). However, at the upcoming June extension, Gig will now be asking for a 6-month extension. And no contribution.
These votes are getting very strategic and if we read the tea leaves as to why Gig is not offering additional funds this time around, it points to an intentional removal of SPAC shareholders via redemption. Why, you ask, would they want to do that? Perhaps to replace those investors with new PIPE investors. Seems like the most logical conclusion. SPAC Investors are generally not too keen on giving teams six additional months without a sweetener, so a near total redemption of the trust followed by a replacement via a PIPE is the most likely answer.
We still have five weeks to go until the vote, so things can still change. Stay tuned for any further updates.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...